Adding metformin to insulin did not improve a composite of microvascular and macrovascular disease in type 2 diabetes

Affiliations

Comment

Vivian Fonseca. Evid Based Med. 2009 Oct.

. 2009 Oct;14(5):139.

doi: 10.1136/ebm.14.5.139.

¹ Scott and White Clinic, Texas A & M Health Sciences Center, Temple, Texas, USA.

No abstract available

Comment on

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
Kooy A, de Jager J, Lehert P, Bets D, Wulffelé MG, Donker AJ, Stehouwer CD. Kooy A, et al. Arch Intern Med. 2009 Mar 23;169(6):616-25. doi: 10.1001/archinternmed.2009.20. Arch Intern Med. 2009. PMID: 19307526 Clinical Trial.

ACP Journal Club. Adding metformin to insulin did not improve a composite of microvascular and macrovascular disease in type 2 diabetes.
Fonseca V. Fonseca V. Ann Intern Med. 2009 Jul 21;151(2):JC1-12. doi: 10.7326/0003-4819-151-2-200907210-02012. Ann Intern Med. 2009. PMID: 19620156 No abstract available.
The metabolic syndrome in type 1 diabetes: does it exist and does it matter?
McGill M, Molyneaux L, Twigg SM, Yue DK. McGill M, et al. J Diabetes Complications. 2008 Jan-Feb;22(1):18-23. doi: 10.1016/j.jdiacomp.2006.10.005. J Diabetes Complications. 2008. PMID: 18191073
Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
Lebovitz HE. Lebovitz HE. Diabetes Care. 1999 Apr;22 Suppl 3:C41-4. Diabetes Care. 1999. PMID: 10189561 Review.
Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
Rensing KL, Reuwer AQ, Arsenault BJ, von der Thüsen JH, Hoekstra JB, Kastelein JJ, Twickler TB. Rensing KL, et al. Diabetes Obes Metab. 2011 Dec;13(12):1073-87. doi: 10.1111/j.1463-1326.2011.01468.x. Diabetes Obes Metab. 2011. PMID: 21736687 Review.
Prevention of type 2 diabetes.
Yale JF. Yale JF. Int J Clin Pract Suppl. 2000 Oct;(113):35-9. Int J Clin Pract Suppl. 2000. PMID: 11965830 Review.